23
Participants
Start Date
November 30, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
July 31, 2013
Ozurdex
"\- Consent agreement - Patients should be informed that it is possible to get an active medication (Ozurdex implant) as an on label indication from the health insurance company if the diagnosis is accepted as an intraocular inflammation form of Uveitis posterior."
Dept. of Ophthalmology, LMU Munich, Munich
Collaborators (1)
Allergan
INDUSTRY
Ludwig-Maximilians - University of Munich
OTHER